Detailed answers about UNIK BIOTHERAPEUTICS LTD, including incorporation, status, business activity, and accounts information.
When was UNIK BIOTHERAPEUTICS LTD founded?
UNIK BIOTHERAPEUTICS LTD was officially incorporated on 1 August 2025 and is registered under company number 16621745. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is UNIK BIOTHERAPEUTICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of UNIK BIOTHERAPEUTICS LTD?
UNIK BIOTHERAPEUTICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does UNIK BIOTHERAPEUTICS LTD do?
UNIK BIOTHERAPEUTICS LTD operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 46460 - Wholesale of pharmaceutical goods, 72190 - Other research and experimental development on natural sciences and engineering, 82990 - Other business support service activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is UNIK BIOTHERAPEUTICS LTD's registered address?
The registered office address of UNIK BIOTHERAPEUTICS LTD is 1.22 INSTITUTE OF CANCER THERAPEUTICS, RICHMOND ROAD, BRADFORD, WEST YORKSHIRE, UNITED KINGDOM, BD7 1DP. This is the official address filed with Companies House for legal and statutory correspondence.
Is UNIK BIOTHERAPEUTICS LTD financially stable?
Financial accounts for UNIK BIOTHERAPEUTICS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.